CHICAGO (MedPage Today) —The kinase inhibitor sorafenib (Nexavar) keeps metastatic differentiated thyroid cancer from progressing after it stops responding to standard radioiodine,the DECISION trial showed. MedPageToday.com –medical news plus CME for physicians
| |||||
       
Bertalan Mesko,MD,PhD    Alzheimer's Disease Education & Referral Center  Colorectal Cancer Screen  CDC.gov  
 | Nature Reviews Endocrinology 9,253 (2013). doi:10.1038/nrendo.2013.48 Author:Carol Wilson The MAPK kinase inhibitor selumetinib induces radioiodine (131I) uptake and retention in human thyroid tumours that were previously refractory to radioiodine treatment,report researchers.The prognosis of patients with metastatic thyroid cancers resistant to radioiodine therapy is poor. However,preclinical data indicate that [...] Nature Reviews Endocrinology 9,252 (2013). doi:10.1038/nrendo.2013.60 Author:Linda Koch Overweight or excessive weight gain in childhood increase the susceptibility to hypothyroidism or thyroid autoimmunity later in life,particularly in women,a new study published in the Journal of Clinical Endocrinology and Metabolism shows.Previous studies have revealed a complex bidirectional relationship between body [...] More than a quarter of a century after the Chernobyl nuclear disaster,many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission,according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology &Metabolism (JCEM). Newswise:MedNews [...] More than a quarter of a century after the Chernobyl nuclear disaster,many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission,according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology &Metabolism (JCEM). Newswise:MedNews [...] More than a quarter of a century after the Chernobyl nuclear disaster,many children and teenagers who developed thyroid cancer due to radiation are in complete or near remission,according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology &Metabolism (JCEM). Newswise:MedNews [...] A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial,say researchers at Mayo Clinic in Florida. Mayo Clinic Research News and Discovery’s Edge Harvard Women’s Health Watch;01/01/2013 (AN 2011795037) CINAHL Plus with Full Text “Harvard Women’s Health Watch”on 2009-06-03 11:23 AM Late stage thyroid cancer patients with aggressive disease may benefit from a genetic test,but experts caution that use of this test in early stage patients is inappropriate because it is unlikely to lead to better outcomes. Testing for BRAF V600E-positive tumors should be reserved for patients older than 45 who have more advanced disease,[...] Well well well,dare I say the times are changing? Not long ago all we ever heard was “Stay off the internet.”But a friend just said his endocrinologist and his radiologist BOTH recommended ThyCa.org to him! (Twitter:@ThyCaInc) It’s “created and maintained by thyroid cancer survivors,”with a long list of physicians as partners [...] |
  --------------------------------------
University of Washington - Seattle,WA --------------------------------------  --------------------------------------  University of Washington - Harborview Medical CenterSeattle,WA   Office on Women's Health U.S. Department of Health and Human Services      "Watch your weight & your waist!"     CDC:Public Health
  
 U.S. Department of Health & Human ServicesNational Health Information Center
  | |||
| Copyright © 2013 Knowledge of Medicine - All Rights Reserved | Mission Statement | About Us | Contact Us | Hosted &Designed Whelan Technologies | Submit an Article | | |||||
